Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid withdrawal versus maintenance with Tacrobell and Myfortic in low-risk kidney transplant recipients
KCT0000664Phase 4Terminated
- Sponsor
- Korean Society of Nephrology
- Start
- Sep 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus, mycophenolate sodium, prednisolone, methylprednisolone in end-stage kidney disease (ESKD), sponsored by Korean Society of Nephrology. Started Sep 2008; status: terminated.
02
Drugs
tacrolimusmycophenolate sodiumprednisolonemethylprednisolone
03
Conditions
end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on KCT0000664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000664.